UpHealth, Inc (UPHL) Fair Value & Analysis
Healthcare · US · Market cap $1.9K
UpHealth, Inc
UPHL · US
Fair value as of: Jun 26, 2026
From 1 valuation models · updated 7 days ago
Fair value updated Jun 26, 2026 — revised from $13.10 to $0.0005 (−100.0%) since Jun 25, 2026.
Price vs Fair Value (12 months)
12‑month range $0.0005 – $0.0025 · the $0.0005 price screens above the $0.0005 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
UpHealth, Inc (UPHL) currently trades at $0.0005, while our model-based Fair Value estimate is $0.0005 — implying the stock looks roughly 0.4% overvalued today. We read business quality at 30/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, UpHealth, Inc generated revenue of $105M at a net margin of -23.1%. It earns a return on equity of -58.9%. Net debt stands at $151M. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
UpHealth, Inc. provides behavioral health and pharmacy services in the United States. The company offers behavioral healthcare treatment services by utilizing psychiatrists, physicians, advanced nurse practitioners, physician assistants, psychologists, licensed therapists, and clinical social workers. UpHealth, Inc. is headquartered in Delray Beach, Florida.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
UpHealth, Inc reported revenue of $130M in FY2024 versus $5.4M in FY2020, a compound +121.5%/yr. Reported net income was −$57.8M in FY2024.
Is UPHL fairly valued? → Check now
Similar stocks
6 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $172.61 | $104.16 | -40% |
| Pro Medicus Limited PME | A$161.58 | A$33.82 | -79% |
| BrightSpring Health Services, Inc BTSG | $67.20 | $26.39 | -61% |
| Tempus AI, Inc TEM | $48.61 | $12.67 | -74% |
| HealthEquity, Inc HQY | $84.92 | $56.63 | -33% |
| M3, Inc MTHRY | $5.20 | $5.32 | +2% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is UpHealth, Inc (UPHL) undervalued?
What is the fair value of UPHL?
What is the quality score of UPHL?
What is the revenue of UpHealth, Inc (UPHL)?
What is the net profit margin of UPHL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.